Reply to: "5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Was an accurate statistical analysis performed?"

J Hepatol. 2024 Apr;80(4):e162-e163. doi: 10.1016/j.jhep.2023.11.025. Epub 2023 Dec 13.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Folic Acid / analogs & derivatives*
  • Hemodynamics
  • Humans
  • Liver Cirrhosis / drug therapy
  • Portal Pressure*
  • Propranolol* / therapeutic use

Substances

  • Propranolol
  • 5,11-methenyltetrahydrohomofolate
  • Adrenergic beta-Antagonists
  • Folic Acid